| | | | Speaker: Larry Siever, M.D. | | | | At the completion of this session, the participant should be able to: | | | | 1. Learn that borderline personality disorders have neurobiological substrates. | | 2. Understand that these substrates provide a rationale for pharmacotherapy. | | 3. Understand that the neurobiology of borderline personality disorder has implications for psychosocial treatment. |
|
| |
